SEC Shareholder Rule, a Nobel for Optogenetics, Messi & More | A Cup of Alerts

Five stories worth watching this week: the SEC's proposal to rescind Rule 14a-8 on shareholder proposals, the Nobel Prize in Medicine for optogenetics, Lionel Messi's last game for Argentina, TSMC's third-quarter report on October 15, and new conditions on H-1B visas. Then we go deeper on the Nobel and on Messi's farewell, because both come down to the assumptions a plan rests on and who bears the cost if they fail. Chapters 00:00 Intro and this week's lens 01:12 Alert 1: SEC proposes rescinding Rule 14a-8 02:16 Alert 2: Nobel Prize in Medicine for optogenetics 03:07 Alert 3: Messi's farewell for Argentina 04:07 Alert 4: TSMC reports on October 15 04:50 Alert 5: New conditions on H-1B visas 05:54 In Depth 1: A prize is not an approval 07:46 In Depth 2: Messi and the key-person question 09:16 Klexa Decision Map 09:45 The Diagnostic, Wednesday October 14, and close Klexa Beat: https://klexabeat.com Klexa Diagnostic: https://klexagroup.com/governance-dia... LinkedIn: https://www.linkedin.com/build-relati... Primary sources: Securities and Exchange Commission (Federal Register, 91 FR 59904); Nobel Assembly at Karolinska Institutet; TSMC; White House and Department of Homeland Security. General information and commentary only. No professional-client relationship is created. Information is current as of the recording date. #KlexaBeat #ACupOfAlerts